Vanderbilt Heart and Vascular Institute (VHVI)

June 9, 2021

Anticoagulation Clinic at Vanderbilt Heart designated an Anticoagulation Center of Excellence

The Anticoagulation Clinic at Vanderbilt Heart and Vascular Institute (VHVI) has been designated an Anticoagulation Center of Excellence by the Anticoagulation Forum, one of only three in Tennessee.

By Matt Batcheldor
April 8, 2021

New Clinician Spotlight: Matthews Chacko

Matthews Chacko, MD, has joined Vanderbilt Heart and Vascular Institute as an assistant professor of Medicine, an interventional cardiologist and the director of peripheral vascular interventions.

By VUMC News and Communications
The diversity represented at Vanderbilt Heart Murfreesboro includes, from left, Ahmad Abu-Halimah, MD, Murali Kolli, MD, Ravinder Manda, MD, and David Dantzler, MD.
March 10, 2021

Murfreesboro heart clinic reveals power of diversity

In suburban Murfreesboro, just a short drive off Interstate 24, is one of the most diverse practices and clinics in Vanderbilt Health.

By Matt Batcheldor
February 25, 2021

Driven by passion and persistence, Kim Arnold goes above and beyond to help patients

“Her service and love for our patients translates directly with her quality of work.”

By Matt Batcheldor
January 21, 2021

Congenital Heart Program gains accreditation from ACHA

The Adult Congenital Heart Association (ACHA) has awarded the Vanderbilt Adult Congenital Heart Program status as an Adult Congenital Heart Disease (ACHD) Accredited Comprehensive Care Center — the first in Tennessee.

By Matt Batcheldor
January 7, 2021

Freedman named director of the Division of Cardiovascular Medicine

Jane Freedman, MD, will join Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute, effective Aug. 1.

By Matt Batcheldor
December 10, 2020

VHVI’s Brown, Agrawal receive American Heart Association awards

Two Vanderbilt Heart and Vascular Institute researchers are receiving awards from the American Heart Association.
By Matt Batcheldor
October 22, 2020

Minimally invasive treatment option for AFib studied

A minimally invasive procedure that combines ligation of the left atrial appendage (LAA) with hybrid epicardial-endocardial ablation is a feasible, safe and effective method of treating patients with longstanding atrial fibrillation (AF or AFib), according to a new Vanderbilt-led study.
By Matt Batcheldor
September 17, 2020

New device may aid advanced heart failure patients

Vanderbilt Heart and Vascular Institute (VHVI) has implanted its first V-Wave, an interatrial shunt device, as a part of a multi-center clinical trial.
By Matt Batcheldor
July 30, 2020

Device allows VHVI doctors to monitor heart patients remotely

In 2018, Ronnie Kreis began to develop severe heart failure. After being hospitalized multiple times that year near his home in Oliver Springs in East Tennessee, he was told that nothing else could be done.
By Matt Batcheldor
May 6, 2020

Ventricular assist device program hits major milestone

VHVI’s cardiac surgery and heart failure teams recently celebrated a milestone — implanting the 500th adult patient with a ventricular assist device.
By Matt Batcheldor
March 12, 2020

Tiny pacemaker helps keep patient’s heart in rhythm

In February, Martha Hawks became the Southeast’s first recipient of the Medtronic Micra AV, the latest version of the tiny pacemaker that Vanderbilt Heart and Vascular Institute began testing in a clinical trial in 2014. The FDA approved the latest device in January.
By Matt Batcheldor
January 9, 2020

Interim directors of Cardiovascular Medicine named

Dan Roden, MD, and Daniel Munoz, have been named interim directors of the Division of Cardiovascular Medicine at Vanderbilt University Medical Center.
By Matt Batcheldor
1 2 3 4 5 … 10